Testosterone Treatment Lawsuit News: Written Discovery Schedule Established in Federal Testosterone Litigation, Bernstein Liebhard LLP Reports

Share Article

The Firm is potential evaluating testosterone lawsuits on behalf of men who suffered serious cardiovascular problems allegedly due to their use of AndroGel and other low testosterone therapy medications.

Free Case Review
We are pleased that the federal testosterone lawsuits are moving forward, and will continue to monitor their progress.

Hundreds of testosterone treatment lawsuits (http://www.testosteronelawsuithub.com/) filed on behalf of men who were allegedly injured due to their use of AndroGel and other low testosterone therapies continue to move forward in a multidistrict litigation now underway in U.S. District Court, Northern District of Illinois, Bernstein Liebhard LLP reports. According to a Case Management Order dated October 31, 2014, the Court has established a schedule which governs certain matters pertaining to written discovery. Among other things, the Order directs AbbVie, Inc. defendants to provide plaintiffs’ attorneys with interrogatory responses and references to requested documents on or before November 14, 2014. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

“Our Firm has heard from many men who allegedly suffered heart attacks, strokes, blood clots and other serious cardiovascular problems due their use of low testosterone therapy drugs. We are pleased that the federal testosterone lawsuits are moving forward, and will continue to monitor their progress,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now offering free case reviews to victims of heart attacks, strokes, deep vein thrombosis, pulmonary embolism and other life-threatening heart problems that were allegedly caused by prescription testosterone medication.

Testosterone Treatment Litigation
Court documents indicate that more than 220 testosterone treatment lawsuits have been filed in the Northern District of Illinois on behalf of men who allegedly experienced serious heart problems due to their use of AndroGel and similar drugs. Among other things, plaintiffs in these cases allege that the manufacturers of low testosterone therapies failed to warn doctors and patients about their potential cardiovascular risks, and concealed those dangers from the public.

Since January, testosterone replacement medications have been the subject of a U.S. Food & Drug Administration (FDA) safety review that was launched after two studies suggested that testosterone replacement therapies might increase the likelihood that older men, or those with pre-existing heart disease, will experience heart attacks, strokes or death. In September, a panel of outside advisors convened by the FDA recommended that the manufacturers of the medications be required to conduct studies of their cardiovascular side effects. The advisors also recommended that the labeling for low testosterone therapies be revised to make clear they have not been shown to lessen low libido, fatigue, muscle loss and other symptoms commonly experienced by aging men.**

Victims of heart attacks, strokes, blood clots and other cardiovascular events allegedly related to the use of low testosterone therapy may be entitled to compensation from the manufacturer of the medication they used. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*reuters.com/article/2014/09/17/us-usa-health-testosterone-idUSKBN0HC2C320140917, Reuters, September 18, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website